Daily Market Brief · Monday, 8 June 2026

Yuan Dao Communications faces potential illegal delisting amid CSRC investigation

Yuan Dao Communications Co., Ltd. warns investors of possible illegal forced delisting due to financial misrepresentation allegations. Meanwhile, Alnera Aluminium and Gote Electronics announce significant asset acquisitions and IPO plans.

62 material announcements from 46 companies

Today’s market saw significant developments, particularly concerning Yuan Dao Communications Co., Ltd. (301139), which may face illegal forced delisting following a preliminary notice from the China Securities Regulatory Commission (CSRC). The company is under investigation for alleged financial data misrepresentation, prompting a risk warning for investors.

Earnings & Performance

  • Yuan Dao Communications Co., Ltd. (301139): The company issued a sixth risk warning regarding potential illegal forced delisting due to ongoing investigations by the CSRC.

Deals & Restructuring

  • Alnera Aluminium Co., Ltd. (301613): Announced plans to acquire 100% of Honglian Electronics for 1.22 billion RMB through a combination of share issuance and cash payment. The transaction aims to enhance operational scale and profitability.
  • Gote Electronics Co., Ltd. (301669): Set to list on the ChiNext Market on June 9, 2026, following an IPO of 120 million shares. The total share capital post-IPO will be 480 million shares.
  • Zhongnanhong Culture Group Co., Ltd. (002445): Progressing on a major asset restructuring to acquire a 57.30% stake in Jiangyin Sulong Thermal Power Co., Ltd., pending audits and regulatory approvals.
  • Hangxin Technology Co., Ltd. (300424): Announced early redemption of convertible bonds effective July 8, 2026, at a price of 102.885 CNY per bond.

Regulatory & Governance

  • Pairui Co., Ltd. (300831): Received a notice of administrative penalty from the CSRC for suspected violations, facing fines totaling 4.4 million yuan. The company plans to enhance internal controls.
  • Weiteou Co., Ltd. (301319): Reported significant stock price fluctuations, prompting regulatory scrutiny due to a P/E ratio significantly above industry averages.

Other Notable Developments

  • Lepu Medical Technology (Beijing) Co., Ltd. (300003): Its subsidiary has received approval for a Phase I clinical trial of the dual-target siRNA drug MWX205 in Australia.
  • Yifan Transmission Co., Ltd. (301023): Completed the acquisition of 40% equity in Beijing Helish Motor Technology Co., Ltd. for 84 million RMB.
  • Xianhe Environmental Protection Co., Ltd. (300137): Announced plans to issue shares to specific investors for up to 80 million RMB to supplement working capital.
  • Hefei Lifeon Pharmaceutical Co., Ltd. (003020): Completed the transfer of marketing authorization for Mesalazine Enteric-Coated Tablets, expected to positively impact net profit in 2026.
  • Kailong High-Tech Co., Ltd. (300912): Announced a cooperation agreement for Enhanced Geothermal Systems with Power Planet, Inc. at the Star Peak project in Nevada.

In this brief

This brief is generated by AI from English translations of SZSE filings and may contain errors. It is for information only and is not investment advice.